Europe’s drug landscape shifted rapidly in 2025. Indeed, a new report from the European Union Drugs Agency shows how fast synthetic drug threats are reshaping the picture. The agency’s Consolidated Annual Activity Report 2025 covers its first full year under an expanded mandate. Specifically, it points to a continent grappling with potent new substances entering the market. Meanwhile, authorities are scrambling to keep pace.

The agency was formerly known as the European Monitoring Centre for Drugs and Drug Addiction. It took on broader powers in July 2024. Since then, it has built new systems to spot synthetic drug threats earlier. The goal is to respond before threats spread further into communities.

Synthetic Drug Threats Trigger a Wave of New Warnings

Officials issued formal notifications for 50 new psychoactive substances under the EU Early Warning System during 2025 alone. Three of these substances were synthetic cathinones known as 2 MMC, 4 BMC and NEP. Subsequently, all three moved quickly through risk assessment. As a result, they are now classified as controlled drugs under EU law.

Meanwhile, the agency’s first pilot threat assessment was published in June. It examined the growing availability and harm of highly potent synthetic opioids in the Baltic region. Nitazenes are a class of synthetic opioids many times stronger than heroin. Notably, this class featured prominently among the substances flagged. To help laboratories keep up, the EUDA distributed a new reference kit. The kit contains samples of fourteen synthetic opioids. It went to a network of sixty three forensic and toxicological laboratories. These laboratories span the EU, Norway and Türkiye.

A further safeguard arrived in November. The European Drug Alert System launched officially that month. In effect, it issues rapid notices whenever a serious risk of European relevance emerges. Three risk communications went out under the new system within its first months. Six related health advisories followed alongside them.

Mapping How Far Synthetic Drug Threats Have Spread

Wastewater testing covered a record one hundred twenty eight cities in twenty six countries. It found rising traces of MDMA, cocaine and amphetamine. Cannabis detection eased slightly by comparison. Separately, a survey reached more than sixty six thousand adults across thirty five countries. In turn, it offered fresh insight into patterns of use and polysubstance combinations.

The agency’s flagship European Drug Report is now in its thirtieth edition. It drew on data from twenty nine countries. The report singled out synthetic cathinones, potent cannabis products and highly potent synthetic opioids. These are the novel psychoactive substances most likely to challenge Europe’s readiness in the years ahead. Officials launched the report in Lisbon. The European Commissioner for Internal Affairs and Migration joined them there. He also described it as critical evidence behind the bloc’s response to illegal drug supply networks.

Young people also remain a particular focus. The European School Survey Project on Alcohol and Other Drugs tracks substance use among fifteen and sixteen year old students. It released its latest findings in May. The data gives researchers a way to track emerging risk behaviours among adolescents across the continent.

Building Prevention Against Synthetic Drug Threats

Faced with this shifting landscape, the EUDA leaned heavily on education and early intervention. Its European Prevention Curriculum trained one hundred thirty six participants through basic and advanced courses in 2025. In addition, a dedicated summer school in Lisbon focused specifically on synthetic opioids. It welcomed fifty five participants from thirty nations.

Overall, the agency trained more than two thousand one hundred professionals during the year. Over one thousand eight hundred of these were law enforcement officers. They also worked alongside the European Union Agency for Law Enforcement Training. A further twelve hundred people joined agency webinars. Fifty four news outputs also reached an audience of two point three million unique website visitors.

On the policy front, the EUDA contributed technical input too. This supported the EU Drugs Strategy and the EU Action Plan against Drug Trafficking. Both were released in December. The agency also completed nine assessments of precursor chemicals. These chemicals are used to manufacture synthetic cathinones and amphetamine. Officials say this work is therefore essential for cutting supply before substances ever reach the street.

Looking ahead, Lorraine Nolan takes over as the new Executive Director from January 2026. She has signalled that the next strategy will lean further into prevention focused preparedness. Synthetic drug threats continue to evolve faster than regulation alone can manage. However, the report makes one thing clear. Early warning, education and demand reduction sit at the heart of Europe’s response.

Source: dbrecoveryresources